CellType
The agentic drug company. We simulate human biology.
New York City, NY
5 employees
Drug Discovery and Delivery
Pre-seed · $500K
About CellType
The agentic drug company. We simulate human biology.
The agentic drug company. We simulate human biology.
The agentic drug company. We simulate human biology.
Total raised
$500K
Last stage
Pre-seed
Investors
David van Dijk
Co-Founder & CEO of CellType (W26). Yale Professor, 11,000+ citations. Built biological foundation models with Google. Building the agentic drug company.
LinkedIn
Ivan Vrkic
Co-Founder @ CellType (W26). ML @ Yale & EPFL. Building the next-generation agentic drug company. Co-developed our core technology Cell2Sentence at Yale and published at ICML. Previously led large-scale foundation model training at a biotech startup and built software to control CERN's Large Hadron Collider.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.